HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C B Moore Selected Research

Flucytosine (Ancobon)

8/2002In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C B Moore Research Topics

Disease

5Aspergillosis
06/2015 - 01/2000
5Hypersensitivity (Allergy)
05/2003 - 07/2000
2Pulmonary Aspergillosis
04/2013 - 06/2012
2Body Weight (Weight, Body)
12/2002 - 10/2000
1Allergic Bronchopulmonary Aspergillosis
04/2013
1Mannose-Binding Protein Deficiency
06/2012
1Hyperlactatemia
04/2001
1Lactic Acidosis
04/2001
1Nausea
04/2001
1Candidiasis (Moniliasis)
10/2000
1Insulin Resistance
07/2000
1HIV Infections (HIV Infection)
07/2000

Drug/Important Bio-Agent (IBA)

5PhytohemagglutininsIBA
05/2003 - 07/2000
4phytohemagglutinin-PIBA
05/2003 - 07/2000
2AzolesIBA
06/2015 - 08/2002
2Amphotericin B (Amphotericin)FDA LinkGeneric
08/2002 - 01/2000
2NucleosidesIBA
04/2001 - 07/2000
2Reverse Transcriptase InhibitorsIBA
04/2001 - 07/2000
1Immunoglobulin G (IgG)IBA
04/2013
1AntibodiesIBA
04/2013
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
06/2012
1MelatoninIBA
12/2002
1Terbinafine (Lamisil)FDA LinkGeneric
08/2002
1Flucytosine (Ancobon)FDA Link
08/2002
1Protease Inhibitors (Protease Inhibitor)IBA
04/2001
1Stavudine (Zerit)FDA LinkGeneric
04/2001
1Lactic Acid (Lactate)FDA LinkGeneric
04/2001
1liposomal amphotericin BFDA Link
10/2000
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2000
1Fluconazole (Zonal)FDA LinkGeneric
10/2000
1HIV Protease InhibitorsIBA
07/2000

Therapy/Procedure

4Therapeutics
08/2002 - 01/2000
1Highly Active Antiretroviral Therapy (HAART)
04/2001